| Patents for C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids (89,892) |
|---|
| 07/21/2011 | US20110177519 Method for Detecting Functional Mold, Method for Evaluating Functional Mold-Containing Product and Primer Pair |
| 07/21/2011 | US20110177509 Risk factors and a therapeutic target for neurodegenerative disorders |
| 07/21/2011 | US20110177508 Universal methylation profiling methods |
| 07/21/2011 | US20110177502 Identification of pediatric onset inflammatory disease loci and methods of use thereof for the diagnosis and treatment of the same |
| 07/21/2011 | US20110177498 Base-detecting pore |
| 07/21/2011 | US20110177496 Field-switch sequencing |
| 07/21/2011 | US20110177493 Using highly sensitive suspended carbon nanotubes for molecular-level sensing based on optical detection |
| 07/21/2011 | US20110177228 Plant nucelotide sequences and corresponding polypeptides |
| 07/21/2011 | US20110177154 Tubular nanostructure targeted to cell membrane |
| 07/21/2011 | US20110177131 siRNA SILENCING OF FILOVIRUS GENE EXPRESSION |
| 07/21/2011 | US20110177124 Codon-optimized polynucleotide-based vaccines against human cytomegalovirus infection |
| 07/21/2011 | US20110177117 Chimeric respiratory syncytial virus polypeptide antigens |
| 07/21/2011 | US20110177110 Compositions comprising cationic microparticles and hcv e1e2 dna and methods of use thereof |
| 07/21/2011 | US20110177107 Predicting and reducing alloimmunogenicity of protein therapeutics |
| 07/21/2011 | US20110177096 Use of gpr151 modulators for the treatment of pain |
| 07/21/2011 | US20110177095 Anti-her2 antibodies and their uses |
| 07/21/2011 | US20110177085 Bitter Taste Receptors |
| 07/21/2011 | US20110177082 Compositions and methods for the therapy and diagnosis of ovarian cancer |
| 07/21/2011 | US20110177076 Humanized anti-amyloid beta antibodies |
| 07/21/2011 | US20110177074 Compositions and methods for inhibiting pdgfrbeta and vegf-a |
| 07/21/2011 | US20110177070 TGF-Beta Antagonist Multi-Target Binding Proteins |
| 07/21/2011 | US20110177056 Non-cytotoxic fusion proteins comprising egf muteins |
| 07/21/2011 | US20110177029 O-linked glycosylation using n-acetylglucosaminyl transferases |
| 07/21/2011 | US20110177022 Mammalian Cytokines; Related Reagents and Methods |
| 07/21/2011 | US20110177007 Dithienopyrrole Dyes for Imaging and Therapy |
| 07/21/2011 | US20110177006 Dithienofuran Dyes for Imaging and Therapy |
| 07/21/2011 | US20110177003 Proteins that fluoresce at infrared wavelengths or generate singlet oxygen upon illumination |
| 07/21/2011 | US20110176996 Compositions and methods for cancer management using antibodies binding to nucleotide salvage pathway enzymes and complexes thereof |
| 07/21/2011 | US20110174322 Alteration of tobacco alkaloid content through modification of specific cytochrome p450 genes |
| 07/21/2011 | DE102010004957A1 Biologisch wirksame Moleküle zur Beeinflussung von Virus-, Bakterien-, Parasiten-infizierten Zellen und/oder Tumorzellen und Verfahren zu deren Anwendung Biologically active molecules for influencing viral, bacterial, parasite-infected cells and / or tumor cells and methods of use thereof |
| 07/21/2011 | CA2786696A1 Oligonucleotides and methods for detecting kras and pik3ca mutations |
| 07/20/2011 | EP2345745A1 Methods and nucleic acids for analyses of colorectal cell proliferative disorders |
| 07/20/2011 | EP2345742A1 RNA sequence-specific mediators of RNA interference |
| 07/20/2011 | EP2345730A1 Arabidopsis genes encoding proteins involved in sugar and lipid metabolism and methods of use |
| 07/20/2011 | EP2345720A2 In vivo production of small interfering RNAs that mediate gene silencing |
| 07/20/2011 | EP2345718A2 Compositions and methods for siRNA inhibition of angiogenesis |
| 07/20/2011 | EP2345662A1 Genetically modified yeast species and fermentation processes using genetically modified yeast |
| 07/20/2011 | EP2344639A2 Compositions and methods for inhibiting expression of transthyretin |
| 07/20/2011 | EP2344514A2 Synthetic methods and derivatives of triphosphate oligonucleotides |
| 07/20/2011 | EP2344174A1 Nucleic acids encoding peptides for treating wounds, anti-angiogenic compounds, and uses thereof |
| 07/20/2011 | EP1230340B1 Methods for the electronic, homogeneous assembly and fabrication of devices |
| 07/20/2011 | CN1978466B Transduction peptide-human brain-derived neurotrophic factor fusion protein and its use |
| 07/20/2011 | CN102127539A MicroRNA and methods for inhibiting same |
| 07/20/2011 | CN101063113B Clone and expression for novel phytase |
| 07/19/2011 | US7982094 Gene encoding lignan methylation enzyme |
| 07/19/2011 | US7982092 Chimeric gene comprising intron from histone H3.3 gene |
| 07/19/2011 | US7982030 Synthesis of selenium-derivatized nucleosides, nucleotides, phosphoramidites, triphosphates and nucleic acids |
| 07/19/2011 | US7982029 Synthesis of four color 3′O-allyl, modified photocleavable fluorescent nucleotides and related methods |
| 07/19/2011 | US7982028 Oligonucleotides affecting expression of phosphodiesterases |
| 07/19/2011 | US7982027 Lipid encapsulated interfering RNA |
| 07/19/2011 | US7982026 FRET probes for fluorescent detection of the ESPS gene |
| 07/19/2011 | US7982025 Fusion proteins of Mycobacterium tuberculosis |
| 07/19/2011 | US7982024 Antibodies to insulin-like growth factor I receptor |
| 07/19/2011 | US7982023 Bag proteins and nucleic acid molecules encoding them |
| 07/19/2011 | US7982022 System for monitoring the location of transgenes |
| 07/19/2011 | US7982021 Fusion proteins comprising pleckstrin homology domain of Akt (protein kinase B) and a pseudoligand containing acidic amino acid residues, sandwiched between resonance energy transfer (RET) pairs, such as cyan and yellow mutants of green fluorescent protein; high throughput assay; drug screening |
| 07/19/2011 | US7982020 Variant polynucleotide for increasing L-proline production |
| 07/19/2011 | US7982004 Nucleic acid and corresponding protein entitled 161P5C5 useful in treatment and detection of cancer |
| 07/19/2011 | US7981870 RNAi-mediated inhibition of H1F1A for treatment of ocular angiogenesis |
| 07/19/2011 | US7981869 RNAi modulation of RSV and therapeutic uses thereof |
| 07/19/2011 | US7981868 Antisense oligonucleotide chemically modified with a phosphorothioate linkage, a 2'-O-methoxyethyl modified sugar, or 5-methylated cytosine; antiinflammatory agents that reduce mucus production in airways |
| 07/19/2011 | US7981843 Antibody specificity transfer using minimal essential binding determinants |
| 07/19/2011 | US7981677 Identifying a high oil phenotype in maize by detecting a marker locus genetically linked with a QTL6 region |
| 07/19/2011 | US7981675 LITAF binding site peptides and methods of using the same |
| 07/19/2011 | US7981658 Nucleic acid molecules, vectors, and host cells encoding fluorescent protein |
| 07/19/2011 | US7981656 Pseudotyped retrovirus with modified ebola glycoprotein |
| 07/19/2011 | US7981655 Modified cytosine deaminases |
| 07/19/2011 | US7981654 Cellulases and their uses |
| 07/19/2011 | US7981652 Modified cytochrome P450 monooxygenases |
| 07/19/2011 | US7981651 Lactobacillus acidophilus nucleic acids and uses thereof |
| 07/19/2011 | US7981637 Fluorescent protein and chromoprotein |
| 07/19/2011 | US7981620 Artificial antibody polypeptides |
| 07/19/2011 | US7981618 Diagnostic and therapeutic methods and compositions involving PTEN and breast cancer |
| 07/19/2011 | US7981615 Compositions and methods for treating diseases associated with T-box and N-Myc |
| 07/19/2011 | US7981614 Methods for generating polynucleotides having desired characteristics by iterative selection and recombination |
| 07/19/2011 | US7981608 Device and method for high-throughput quantification of MRNA from whole blood |
| 07/19/2011 | US7981604 Methods and kits for analyzing polynucleotide sequences |
| 07/19/2011 | US7981603 Using differentially methylated genomic regions (DMR) associated with insulin-like growth factor gene to diagnose/prognose colorectal and other cell proliferative disorders |
| 07/19/2011 | US7981599 Non-nucleic acid probes, probe sets, methods and kits pertaining to the detection of individual human chromosomes X, Y, 1, 2, 3, 4, 6, 7, 8, 9, 10, 11, 12, 16, 17, 18 and 20 as 13/21 as a pair |
| 07/19/2011 | US7981416 Humanized immunomodulatory monoclonal antibodies for the treatment of immunodeficiency |
| 07/19/2011 | CA2553286C Method for detecting pathogenic mycobacteria in clinical specimens |
| 07/19/2011 | CA2314663C A composition for providing long term stability to cells for diagnostic testing |
| 07/19/2011 | CA2185656C Protein tyrosine kinase agonist antibodies |
| 07/19/2011 | CA1341618C Isolation cloning and expression of primate gm-csf |
| 07/14/2011 | WO2011085102A1 Base modified bicyclic nucleosides and oligomeric compounds prepared therefrom |
| 07/14/2011 | WO2011084718A1 Plant genes associated with seed oil content and methods of their use |
| 07/14/2011 | WO2011084370A1 Constitutive synthetic plant promoters and methods of use |
| 07/14/2011 | WO2011083466A1 Compositions and methods for treating glioblastoma gbm |
| 07/14/2011 | WO2011082455A1 Endophytes and related methods |
| 07/14/2011 | WO2011061373A3 Quantification of bovine polyomavirus (bpyv) for tracing bovine contamination in the environment |
| 07/14/2011 | WO2011058446A3 Thebaine 6-o-demethylase and codeine o-demethylase from papaver somniferum |
| 07/14/2011 | WO2011036328A3 Method for early detection of resistance to antiretroviral therapy in hiv |
| 07/14/2011 | WO2008060632A3 1' - substituted ribose 5 ' - polyphosphate analogs and their use as modulators of p2y receptor activity |
| 07/14/2011 | US20110173725 Nucleotide sequences mediating plant male fertility and method of using same |
| 07/14/2011 | US20110173724 Triterpene oxidase derived from plant belonging to genus glychyrrhiza, gene encoding the triterpene oxidase, and use of the protein or the gene |
| 07/14/2011 | US20110173723 EG82013 and EG81345 Nucleic Acids and Uses Thereof |
| 07/14/2011 | US20110173722 Novel insulin derivatives having an extremely delayed time-action profile |
| 07/14/2011 | US20110173721 Reduced risk tobacco products and methods of making same |
| 07/14/2011 | US20110173719 Constitutive promoter from oil palm type 2 |
| 07/14/2011 | US20110173718 Herbicide tolerant plants |